About
Team
Portfolio
Insights
About
Team
Portfolio
Insights
Biopharmaceutical company focused on microRNA (miRNA)-directed oncology therapies
Biopharmaceutical company focused on microRNA (miRNA)-directed oncology therapies
Sectors
Healthcare
Life Sciences
First Invested
2012
Early
Company Status
IPO/Public
NASDAQ: MIRN
Associated Team
Ali Behbahani, MD
Edward Mathers